Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds

A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds

It was much more accurate than primary care doctors using cognitive tests and CT scans. The findings could speed the quest for an affordable and accessible way to diagnose patients with memory problems.